Best Biopharma Outsourcing Companies in Poland
The 36 best Biopharma Outsourcing companies in Poland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: NaturalAntibody.
- market.us
- ResearchAndMarkets.com
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Poland
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NaturalAntibody Provider of data analytic solutions for process of engineering antibody-based therapeutics | $9M | 12 mo ago | Seed | Michał Krawczyk Co-Founder and Board Member | 2020 | Apple iCloud MailGoogle Workspacestyled-components+8 | — | — |
| 2 | Pikralida Provider of research and development services and contract research organization | $3M | 9 mo ago | Seed | Anna Krause Co-Founder & Head of R&D | 2019 | WordPress Block EditorElementorWordPress+26 | 2 patents Synthesis, polymorph control, and formulation of the anticancer drug marimastat | — |
| 3 | PolTREG Developer of cell therapies focused on autoimmune disease treatment | $3M | 58 mo ago | Seed | Piotr Trzonkowski CEO | 2015 | WordPressMySQLPHP+10 | 7 patents Regulatory T‑cell immunotherapy and monitoring methods for type‑1 diabetes treatment | — |
| 4 | AMS Product development company developing solid and specialty dosage forms | $230K | 77 mo ago | Funding Raised | — | 2014 | — | — | — |
| 5 | Mabion Polish, public, clinical-stage, biotech company developing biosimilar monoclonal antibodies for oncology… | — | 82 mo ago | Public | — | 2007 | WordPressMySQLPHP+10 | 12 patents CD20-targeted biologics for multiple sclerosis and recombinant protein manufacturing | 1 partnership |
| 6 | Polpharma Manufacturer of pharmaceuticals and active pharmaceutical ingredients | — | 135 mo ago | Funding Raised | — | 1935 | WordPressMySQLPHP+15 | 9 patents Enhanced drug formulation technologies for solubility and bioavailability improvement. | 1 internship |
| 7 | Sun-Farm Developer of pharmaceutical products and also offers manufacturing services | — | 381 mo ago | Funding Raised | Ran Goren Founder & CEO | 1993 | PHPApache HTTP ServerjQuery UI+3 | — | — |
| 8 | Amorphis Pharma CDMO focused on manufacturing of solid based drugs | — | — | Funding Raised | Justyna Knapik Co-Founder | 2018 | — | — | — |
Top 6 Biopharma Outsourcing companies in Poland
#1
Seed · Szczecin, West Pomeranian Voivodeship · founded 2020 · 16 employees$9.2Mraised▾
Developer of a bioinformatics platform designed to shorten the time of delivering drugs based on antibodies. The company's platform offers an antibody knowledge graph that allows easy access to decades of accumulated knowledge on natural and therapeutic antibodies and antibody analytics, enabling the pharmaceutical industry to reduce the time and costs associated with the delivery of drugs based on antibodies.
- Sep 2025Grant (prize money)$852.4K
- Nov 2024Grant (prize money)$1.2M
- Oct 2024Grant (prize money)$3.4M
- Jun 2024Seed$100.8K
#2
Seed · Poznan, Greater Poland Voivodeship · founded 2019 · 10 employees$3.4Mraised▾
Provider of research and development services and contract research organization. It focuses on clinical-stage projects, creating therapeutic solutions for unmet medical needs. The company develops innovative medicines and offers services for pharmaceutical firms, supporting therapy development and industry innovation. Its primary objective involves establishing a portfolio of projects for potential licensing or sale to pharmaceutical companies for further advancement and global market introduction. The company's main project is developing an active enzyme inhibitor.
- Nov 2025Seed$3.4M
#3
Seed · Gdansk, Pomeranian Voivodeship · founded 2015$3Mraised▾
Developer of cell therapies focused on autoimmune disease treatment. The company focuses on regulatory T lymphocytes for therapeutic applications. It develops therapies for type 1 diabetes and multiple sclerosis. The company also develops new generation products such as CAR-TREGs and tissue-specific TREGs. The company manufactures its own products and provides contract development and manufacturing operation services.
- Oct 2021Grant (prize money)$57.8K
- Nov 2018Grant (prize money)$2.9M
- Dec 2016Grant (prize money)$52.7K
- Dec 2016Seed—
#4
Funding Raised · Suchy Las, Greater Poland Voivodeship · founded 2014 · 2 employees$230.5Kraised▾
AMS (Applied Manufacturing Science) is a GMP-certified company engaged in the manufacturing of complex solid dosage and specialty forms. The company focuses on the product development of challenging and potent APIs to improves their solubility. The key capability of the company is to develop APIs. Its product portfolio includes oro-dispersible dosage forms, inhalation products, and drug delivery systems (vaginal rings, suppositories). The company prepares molecular solutions and dispersions, solid nano-suspensions, co-crystals & amorphous forms using various technologies such as hot-melt extrusion, co-extrusion, die-face pelletization, molding, die casting, and spray drying.
- Apr 2020Grant (prize money)$230.5K
#5
Public · Konstantynow Lodzki, Lodz Voivodeship · founded 2007 · 268 employees—raised▾
Mabion is a Polish, public, clinical-stage, biotech company developing biosimilar monoclonal antibodies for oncology treatment. They want to target market authorization on their own in EU region and in US region. The most advanced candidate is the biosimilar for Rituximab, called MabionCD20, for blood cancers. They are also developing MAb biosimilars to Herceptin (trastuzumab) for breast cancer, Lucentis (Ranimizumab) for vision impairment and Erbitux (Cetuximab) for metastatic colorectal cancer.
#6
Funding Raised · Starogard Gdanski, Pomeranian Voivodeship · founded 1935 · 7000 employees—raised▾
Manufacturer of pharmaceuticals and active pharmaceutical ingredients. It produces a wide variety of medications, including those available over-the-counter and by prescription. The company also engages in research and development, focusing on innovative solutions across its operations. A significant portion of its revenue is reinvested in developing new products and improving its production and laboratory infrastructure to ensure access to effective therapies. It supports scientific advancement through collaborations and funding initiatives.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Poland
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 634 Poland-affiliated papers.
- Institute of Plant Protection85
- Warsaw University of Life Sciences30
- University of Life Sciences in Lublin27
- Ministry of Health25
- Jagiellonian University24
- Gene1→6
- Probiotic1→5
- Nutraceutical1→5
- Enzyme1→4
- Agriculture13
- Antibiotic resistance12
- Context (archaeology)10
- Resistance (ecology)10
- Antimicrobial8
Where biotechnology is researched across Poland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.